nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Infection—Temsirolimus—kidney cancer	0.00649	0.00649	CcSEcCtD
Gadobutrol—Dry mouth—Pazopanib—kidney cancer	0.00628	0.00628	CcSEcCtD
Gadobutrol—Parosmia—Doxorubicin—kidney cancer	0.00624	0.00624	CcSEcCtD
Gadobutrol—Infection—Pazopanib—kidney cancer	0.00612	0.00612	CcSEcCtD
Gadobutrol—Hyperhidrosis—Pazopanib—kidney cancer	0.00595	0.00595	CcSEcCtD
Gadobutrol—Hot flush—Paclitaxel—kidney cancer	0.00593	0.00593	CcSEcCtD
Gadobutrol—Insomnia—Temsirolimus—kidney cancer	0.00591	0.00591	CcSEcCtD
Gadobutrol—Menopausal symptoms—Paclitaxel—kidney cancer	0.00588	0.00588	CcSEcCtD
Gadobutrol—Dysgeusia—Everolimus—kidney cancer	0.00583	0.00583	CcSEcCtD
Gadobutrol—Dyspnoea—Temsirolimus—kidney cancer	0.00583	0.00583	CcSEcCtD
Gadobutrol—Hypoaesthesia—Sunitinib—kidney cancer	0.00569	0.00569	CcSEcCtD
Gadobutrol—Pain—Temsirolimus—kidney cancer	0.00559	0.00559	CcSEcCtD
Gadobutrol—Insomnia—Pazopanib—kidney cancer	0.00557	0.00557	CcSEcCtD
Gadobutrol—Paraesthesia—Pazopanib—kidney cancer	0.00553	0.00553	CcSEcCtD
Gadobutrol—Dyspnoea—Pazopanib—kidney cancer	0.00549	0.00549	CcSEcCtD
Gadobutrol—Abnormal vision—Capecitabine—kidney cancer	0.00547	0.00547	CcSEcCtD
Gadobutrol—Vertigo—Vinblastine—kidney cancer	0.00537	0.00537	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00535	0.00535	CcSEcCtD
Gadobutrol—Pain—Pazopanib—kidney cancer	0.00527	0.00527	CcSEcCtD
Gadobutrol—Palpitations—Everolimus—kidney cancer	0.00526	0.00526	CcSEcCtD
Gadobutrol—Convulsion—Vinblastine—kidney cancer	0.00518	0.00518	CcSEcCtD
Gadobutrol—Abdominal pain—Temsirolimus—kidney cancer	0.00517	0.00517	CcSEcCtD
Gadobutrol—Body temperature increased—Temsirolimus—kidney cancer	0.00517	0.00517	CcSEcCtD
Gadobutrol—Convulsion—Everolimus—kidney cancer	0.00516	0.00516	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00507	0.00507	CcSEcCtD
Gadobutrol—Dysgeusia—Sorafenib—kidney cancer	0.00506	0.00506	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Pazopanib—kidney cancer	0.00504	0.00504	CcSEcCtD
Gadobutrol—Dry mouth—Everolimus—kidney cancer	0.00496	0.00496	CcSEcCtD
Gadobutrol—Injection site pain—Doxorubicin—kidney cancer	0.00495	0.00495	CcSEcCtD
Gadobutrol—Dysgeusia—Sunitinib—kidney cancer	0.00487	0.00487	CcSEcCtD
Gadobutrol—Hot flush—Capecitabine—kidney cancer	0.00487	0.00487	CcSEcCtD
Gadobutrol—Abdominal pain—Pazopanib—kidney cancer	0.00487	0.00487	CcSEcCtD
Gadobutrol—Infection—Everolimus—kidney cancer	0.00483	0.00483	CcSEcCtD
Gadobutrol—Menopausal symptoms—Capecitabine—kidney cancer	0.00483	0.00483	CcSEcCtD
Gadobutrol—Hypersensitivity—Temsirolimus—kidney cancer	0.00482	0.00482	CcSEcCtD
Gadobutrol—Hypoaesthesia—Vincristine—kidney cancer	0.00481	0.00481	CcSEcCtD
Gadobutrol—Hyperhidrosis—Everolimus—kidney cancer	0.0047	0.0047	CcSEcCtD
Gadobutrol—Sweating increased—Paclitaxel—kidney cancer	0.00467	0.00467	CcSEcCtD
Gadobutrol—Infection—Erlotinib—kidney cancer	0.00466	0.00466	CcSEcCtD
Gadobutrol—Diarrhoea—Temsirolimus—kidney cancer	0.00447	0.00447	CcSEcCtD
Gadobutrol—Pollakiuria—Paclitaxel—kidney cancer	0.00443	0.00443	CcSEcCtD
Gadobutrol—Insomnia—Everolimus—kidney cancer	0.0044	0.0044	CcSEcCtD
Gadobutrol—Paraesthesia—Vinblastine—kidney cancer	0.00438	0.00438	CcSEcCtD
Gadobutrol—Paraesthesia—Everolimus—kidney cancer	0.00437	0.00437	CcSEcCtD
Gadobutrol—Dyspnoea—Everolimus—kidney cancer	0.00433	0.00433	CcSEcCtD
Gadobutrol—Dizziness—Temsirolimus—kidney cancer	0.00432	0.00432	CcSEcCtD
Gadobutrol—Convulsion—Sunitinib—kidney cancer	0.00431	0.00431	CcSEcCtD
Gadobutrol—Dry mouth—Sorafenib—kidney cancer	0.00431	0.00431	CcSEcCtD
Gadobutrol—Insomnia—Erlotinib—kidney cancer	0.00424	0.00424	CcSEcCtD
Gadobutrol—Anaphylactic shock—Sorafenib—kidney cancer	0.00422	0.00422	CcSEcCtD
Gadobutrol—Diarrhoea—Pazopanib—kidney cancer	0.00421	0.00421	CcSEcCtD
Gadobutrol—Infection—Sorafenib—kidney cancer	0.00419	0.00419	CcSEcCtD
Gadobutrol—Dyspnoea—Erlotinib—kidney cancer	0.00418	0.00418	CcSEcCtD
Gadobutrol—Pain—Vinblastine—kidney cancer	0.00417	0.00417	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Capecitabine—kidney cancer	0.00416	0.00416	CcSEcCtD
Gadobutrol—Pain—Everolimus—kidney cancer	0.00416	0.00416	CcSEcCtD
Gadobutrol—Vomiting—Temsirolimus—kidney cancer	0.00416	0.00416	CcSEcCtD
Gadobutrol—Dry mouth—Sunitinib—kidney cancer	0.00414	0.00414	CcSEcCtD
Gadobutrol—Rash—Temsirolimus—kidney cancer	0.00412	0.00412	CcSEcCtD
Gadobutrol—Dermatitis—Temsirolimus—kidney cancer	0.00412	0.00412	CcSEcCtD
Gadobutrol—Headache—Temsirolimus—kidney cancer	0.00409	0.00409	CcSEcCtD
Gadobutrol—Dizziness—Pazopanib—kidney cancer	0.00407	0.00407	CcSEcCtD
Gadobutrol—Infection—Sunitinib—kidney cancer	0.00403	0.00403	CcSEcCtD
Gadobutrol—Pain—Erlotinib—kidney cancer	0.00401	0.00401	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Vinblastine—kidney cancer	0.00399	0.00399	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Everolimus—kidney cancer	0.00398	0.00398	CcSEcCtD
Gadobutrol—Vomiting—Pazopanib—kidney cancer	0.00392	0.00392	CcSEcCtD
Gadobutrol—Rash—Pazopanib—kidney cancer	0.00388	0.00388	CcSEcCtD
Gadobutrol—Nausea—Temsirolimus—kidney cancer	0.00388	0.00388	CcSEcCtD
Gadobutrol—Dermatitis—Pazopanib—kidney cancer	0.00388	0.00388	CcSEcCtD
Gadobutrol—Abdominal pain—Vinblastine—kidney cancer	0.00386	0.00386	CcSEcCtD
Gadobutrol—Headache—Pazopanib—kidney cancer	0.00386	0.00386	CcSEcCtD
Gadobutrol—Abdominal pain—Everolimus—kidney cancer	0.00384	0.00384	CcSEcCtD
Gadobutrol—Body temperature increased—Everolimus—kidney cancer	0.00384	0.00384	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Erlotinib—kidney cancer	0.00384	0.00384	CcSEcCtD
Gadobutrol—Sweating increased—Capecitabine—kidney cancer	0.00384	0.00384	CcSEcCtD
Gadobutrol—Hypoaesthesia—Paclitaxel—kidney cancer	0.00382	0.00382	CcSEcCtD
Gadobutrol—Infection—Dactinomycin—kidney cancer	0.00382	0.00382	CcSEcCtD
Gadobutrol—Vertigo—Vincristine—kidney cancer	0.00378	0.00378	CcSEcCtD
Gadobutrol—Dyspnoea—Sorafenib—kidney cancer	0.00376	0.00376	CcSEcCtD
Gadobutrol—Body temperature increased—Erlotinib—kidney cancer	0.00371	0.00371	CcSEcCtD
Gadobutrol—Abdominal pain—Erlotinib—kidney cancer	0.00371	0.00371	CcSEcCtD
Gadobutrol—Visual impairment—Paclitaxel—kidney cancer	0.0037	0.0037	CcSEcCtD
Gadobutrol—Insomnia—Sunitinib—kidney cancer	0.00367	0.00367	CcSEcCtD
Gadobutrol—Nausea—Pazopanib—kidney cancer	0.00366	0.00366	CcSEcCtD
Gadobutrol—Paraesthesia—Sunitinib—kidney cancer	0.00365	0.00365	CcSEcCtD
Gadobutrol—Convulsion—Vincristine—kidney cancer	0.00365	0.00365	CcSEcCtD
Gadobutrol—Dyspnoea—Sunitinib—kidney cancer	0.00362	0.00362	CcSEcCtD
Gadobutrol—Pain—Sorafenib—kidney cancer	0.00361	0.00361	CcSEcCtD
Gadobutrol—Hypersensitivity—Vinblastine—kidney cancer	0.0036	0.0036	CcSEcCtD
Gadobutrol—Hypersensitivity—Everolimus—kidney cancer	0.00358	0.00358	CcSEcCtD
Gadobutrol—Abnormal vision—Doxorubicin—kidney cancer	0.00353	0.00353	CcSEcCtD
Gadobutrol—Pain—Sunitinib—kidney cancer	0.00347	0.00347	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Sorafenib—kidney cancer	0.00345	0.00345	CcSEcCtD
Gadobutrol—Anaphylactic shock—Vincristine—kidney cancer	0.00344	0.00344	CcSEcCtD
Gadobutrol—Infection—Vincristine—kidney cancer	0.00341	0.00341	CcSEcCtD
Gadobutrol—Diarrhoea—Vinblastine—kidney cancer	0.00334	0.00334	CcSEcCtD
Gadobutrol—Abdominal pain—Sorafenib—kidney cancer	0.00334	0.00334	CcSEcCtD
Gadobutrol—Body temperature increased—Sorafenib—kidney cancer	0.00334	0.00334	CcSEcCtD
Gadobutrol—Diarrhoea—Everolimus—kidney cancer	0.00333	0.00333	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Sunitinib—kidney cancer	0.00332	0.00332	CcSEcCtD
Gadobutrol—Hyperhidrosis—Vincristine—kidney cancer	0.00332	0.00332	CcSEcCtD
Gadobutrol—Pain—Dactinomycin—kidney cancer	0.00329	0.00329	CcSEcCtD
Gadobutrol—Dysgeusia—Paclitaxel—kidney cancer	0.00327	0.00327	CcSEcCtD
Gadobutrol—Anaphylactic shock—Gemcitabine—kidney cancer	0.00326	0.00326	CcSEcCtD
Gadobutrol—Infection—Gemcitabine—kidney cancer	0.00324	0.00324	CcSEcCtD
Gadobutrol—Dizziness—Vinblastine—kidney cancer	0.00323	0.00323	CcSEcCtD
Gadobutrol—Dizziness—Everolimus—kidney cancer	0.00322	0.00322	CcSEcCtD
Gadobutrol—Abdominal pain—Sunitinib—kidney cancer	0.00321	0.00321	CcSEcCtD
Gadobutrol—Body temperature increased—Sunitinib—kidney cancer	0.00321	0.00321	CcSEcCtD
Gadobutrol—Diarrhoea—Erlotinib—kidney cancer	0.00321	0.00321	CcSEcCtD
Gadobutrol—Hyperhidrosis—Gemcitabine—kidney cancer	0.00315	0.00315	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00314	0.00314	CcSEcCtD
Gadobutrol—Hot flush—Doxorubicin—kidney cancer	0.00314	0.00314	CcSEcCtD
Gadobutrol—Hypoaesthesia—Capecitabine—kidney cancer	0.00314	0.00314	CcSEcCtD
Gadobutrol—Menopausal symptoms—Doxorubicin—kidney cancer	0.00311	0.00311	CcSEcCtD
Gadobutrol—Hypersensitivity—Sorafenib—kidney cancer	0.00311	0.00311	CcSEcCtD
Gadobutrol—Insomnia—Vincristine—kidney cancer	0.00311	0.00311	CcSEcCtD
Gadobutrol—Vomiting—Vinblastine—kidney cancer	0.0031	0.0031	CcSEcCtD
Gadobutrol—Dizziness—Erlotinib—kidney cancer	0.0031	0.0031	CcSEcCtD
Gadobutrol—Vomiting—Everolimus—kidney cancer	0.00309	0.00309	CcSEcCtD
Gadobutrol—Paraesthesia—Vincristine—kidney cancer	0.00308	0.00308	CcSEcCtD
Gadobutrol—Rash—Everolimus—kidney cancer	0.00307	0.00307	CcSEcCtD
Gadobutrol—Dermatitis—Everolimus—kidney cancer	0.00306	0.00306	CcSEcCtD
Gadobutrol—Headache—Vinblastine—kidney cancer	0.00306	0.00306	CcSEcCtD
Gadobutrol—Headache—Everolimus—kidney cancer	0.00305	0.00305	CcSEcCtD
Gadobutrol—Body temperature increased—Dactinomycin—kidney cancer	0.00304	0.00304	CcSEcCtD
Gadobutrol—Abdominal pain—Dactinomycin—kidney cancer	0.00304	0.00304	CcSEcCtD
Gadobutrol—Visual impairment—Capecitabine—kidney cancer	0.00304	0.00304	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00303	0.00303	CcSEcCtD
Gadobutrol—Vertigo—Paclitaxel—kidney cancer	0.003	0.003	CcSEcCtD
Gadobutrol—Hypersensitivity—Sunitinib—kidney cancer	0.00299	0.00299	CcSEcCtD
Gadobutrol—Vomiting—Erlotinib—kidney cancer	0.00298	0.00298	CcSEcCtD
Gadobutrol—Rash—Erlotinib—kidney cancer	0.00296	0.00296	CcSEcCtD
Gadobutrol—Dermatitis—Erlotinib—kidney cancer	0.00296	0.00296	CcSEcCtD
Gadobutrol—Palpitations—Paclitaxel—kidney cancer	0.00295	0.00295	CcSEcCtD
Gadobutrol—Insomnia—Gemcitabine—kidney cancer	0.00295	0.00295	CcSEcCtD
Gadobutrol—Headache—Erlotinib—kidney cancer	0.00294	0.00294	CcSEcCtD
Gadobutrol—Pain—Vincristine—kidney cancer	0.00294	0.00294	CcSEcCtD
Gadobutrol—Paraesthesia—Gemcitabine—kidney cancer	0.00293	0.00293	CcSEcCtD
Gadobutrol—Dyspnoea—Gemcitabine—kidney cancer	0.00291	0.00291	CcSEcCtD
Gadobutrol—Nausea—Vinblastine—kidney cancer	0.0029	0.0029	CcSEcCtD
Gadobutrol—Convulsion—Paclitaxel—kidney cancer	0.0029	0.0029	CcSEcCtD
Gadobutrol—Nausea—Everolimus—kidney cancer	0.00289	0.00289	CcSEcCtD
Gadobutrol—Diarrhoea—Sorafenib—kidney cancer	0.00289	0.00289	CcSEcCtD
Gadobutrol—Hypersensitivity—Dactinomycin—kidney cancer	0.00283	0.00283	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Vincristine—kidney cancer	0.00281	0.00281	CcSEcCtD
Gadobutrol—Dizziness—Sorafenib—kidney cancer	0.00279	0.00279	CcSEcCtD
Gadobutrol—Pain—Gemcitabine—kidney cancer	0.00279	0.00279	CcSEcCtD
Gadobutrol—Nausea—Erlotinib—kidney cancer	0.00279	0.00279	CcSEcCtD
Gadobutrol—Dry mouth—Paclitaxel—kidney cancer	0.00278	0.00278	CcSEcCtD
Gadobutrol—Diarrhoea—Sunitinib—kidney cancer	0.00278	0.00278	CcSEcCtD
Gadobutrol—Anaphylactic shock—Paclitaxel—kidney cancer	0.00273	0.00273	CcSEcCtD
Gadobutrol—Abdominal pain—Vincristine—kidney cancer	0.00272	0.00272	CcSEcCtD
Gadobutrol—Body temperature increased—Vincristine—kidney cancer	0.00272	0.00272	CcSEcCtD
Gadobutrol—Infection—Paclitaxel—kidney cancer	0.00271	0.00271	CcSEcCtD
Gadobutrol—Dysgeusia—Capecitabine—kidney cancer	0.00269	0.00269	CcSEcCtD
Gadobutrol—Dizziness—Sunitinib—kidney cancer	0.00269	0.00269	CcSEcCtD
Gadobutrol—Vomiting—Sorafenib—kidney cancer	0.00268	0.00268	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00268	0.00268	CcSEcCtD
Gadobutrol—Rash—Sorafenib—kidney cancer	0.00266	0.00266	CcSEcCtD
Gadobutrol—Dermatitis—Sorafenib—kidney cancer	0.00266	0.00266	CcSEcCtD
Gadobutrol—Headache—Sorafenib—kidney cancer	0.00264	0.00264	CcSEcCtD
Gadobutrol—Hyperhidrosis—Paclitaxel—kidney cancer	0.00264	0.00264	CcSEcCtD
Gadobutrol—Diarrhoea—Dactinomycin—kidney cancer	0.00263	0.00263	CcSEcCtD
Gadobutrol—Vomiting—Sunitinib—kidney cancer	0.00258	0.00258	CcSEcCtD
Gadobutrol—Body temperature increased—Gemcitabine—kidney cancer	0.00258	0.00258	CcSEcCtD
Gadobutrol—Rash—Sunitinib—kidney cancer	0.00256	0.00256	CcSEcCtD
Gadobutrol—Dermatitis—Sunitinib—kidney cancer	0.00256	0.00256	CcSEcCtD
Gadobutrol—Headache—Sunitinib—kidney cancer	0.00254	0.00254	CcSEcCtD
Gadobutrol—Hypersensitivity—Vincristine—kidney cancer	0.00253	0.00253	CcSEcCtD
Gadobutrol—Nausea—Sorafenib—kidney cancer	0.00251	0.00251	CcSEcCtD
Gadobutrol—Insomnia—Paclitaxel—kidney cancer	0.00247	0.00247	CcSEcCtD
Gadobutrol—Vertigo—Capecitabine—kidney cancer	0.00246	0.00246	CcSEcCtD
Gadobutrol—Paraesthesia—Paclitaxel—kidney cancer	0.00245	0.00245	CcSEcCtD
Gadobutrol—Vomiting—Dactinomycin—kidney cancer	0.00244	0.00244	CcSEcCtD
Gadobutrol—Dyspnoea—Paclitaxel—kidney cancer	0.00243	0.00243	CcSEcCtD
Gadobutrol—Palpitations—Capecitabine—kidney cancer	0.00242	0.00242	CcSEcCtD
Gadobutrol—Rash—Dactinomycin—kidney cancer	0.00242	0.00242	CcSEcCtD
Gadobutrol—Nausea—Sunitinib—kidney cancer	0.00241	0.00241	CcSEcCtD
Gadobutrol—Diarrhoea—Vincristine—kidney cancer	0.00235	0.00235	CcSEcCtD
Gadobutrol—Pollakiuria—Doxorubicin—kidney cancer	0.00234	0.00234	CcSEcCtD
Gadobutrol—Pain—Paclitaxel—kidney cancer	0.00233	0.00233	CcSEcCtD
Gadobutrol—Dry mouth—Capecitabine—kidney cancer	0.00228	0.00228	CcSEcCtD
Gadobutrol—Nausea—Dactinomycin—kidney cancer	0.00228	0.00228	CcSEcCtD
Gadobutrol—Dizziness—Vincristine—kidney cancer	0.00227	0.00227	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00223	0.00223	CcSEcCtD
Gadobutrol—Diarrhoea—Gemcitabine—kidney cancer	0.00223	0.00223	CcSEcCtD
Gadobutrol—Infection—Capecitabine—kidney cancer	0.00222	0.00222	CcSEcCtD
Gadobutrol—Vomiting—Vincristine—kidney cancer	0.00218	0.00218	CcSEcCtD
Gadobutrol—Rash—Vincristine—kidney cancer	0.00217	0.00217	CcSEcCtD
Gadobutrol—Hyperhidrosis—Capecitabine—kidney cancer	0.00216	0.00216	CcSEcCtD
Gadobutrol—Dermatitis—Vincristine—kidney cancer	0.00216	0.00216	CcSEcCtD
Gadobutrol—Body temperature increased—Paclitaxel—kidney cancer	0.00216	0.00216	CcSEcCtD
Gadobutrol—Abdominal pain—Paclitaxel—kidney cancer	0.00216	0.00216	CcSEcCtD
Gadobutrol—Headache—Vincristine—kidney cancer	0.00215	0.00215	CcSEcCtD
Gadobutrol—Vomiting—Gemcitabine—kidney cancer	0.00207	0.00207	CcSEcCtD
Gadobutrol—Rash—Gemcitabine—kidney cancer	0.00205	0.00205	CcSEcCtD
Gadobutrol—Dermatitis—Gemcitabine—kidney cancer	0.00205	0.00205	CcSEcCtD
Gadobutrol—Headache—Gemcitabine—kidney cancer	0.00204	0.00204	CcSEcCtD
Gadobutrol—Nausea—Vincristine—kidney cancer	0.00204	0.00204	CcSEcCtD
Gadobutrol—Insomnia—Capecitabine—kidney cancer	0.00203	0.00203	CcSEcCtD
Gadobutrol—Hypoaesthesia—Doxorubicin—kidney cancer	0.00202	0.00202	CcSEcCtD
Gadobutrol—Paraesthesia—Capecitabine—kidney cancer	0.00201	0.00201	CcSEcCtD
Gadobutrol—Hypersensitivity—Paclitaxel—kidney cancer	0.00201	0.00201	CcSEcCtD
Gadobutrol—Dyspnoea—Capecitabine—kidney cancer	0.002	0.002	CcSEcCtD
Gadobutrol—Visual impairment—Doxorubicin—kidney cancer	0.00196	0.00196	CcSEcCtD
Gadobutrol—Nausea—Gemcitabine—kidney cancer	0.00194	0.00194	CcSEcCtD
Gadobutrol—Pain—Capecitabine—kidney cancer	0.00191	0.00191	CcSEcCtD
Gadobutrol—Diarrhoea—Paclitaxel—kidney cancer	0.00187	0.00187	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Capecitabine—kidney cancer	0.00183	0.00183	CcSEcCtD
Gadobutrol—Dizziness—Paclitaxel—kidney cancer	0.0018	0.0018	CcSEcCtD
Gadobutrol—Body temperature increased—Capecitabine—kidney cancer	0.00177	0.00177	CcSEcCtD
Gadobutrol—Abdominal pain—Capecitabine—kidney cancer	0.00177	0.00177	CcSEcCtD
Gadobutrol—Vomiting—Paclitaxel—kidney cancer	0.00173	0.00173	CcSEcCtD
Gadobutrol—Dysgeusia—Doxorubicin—kidney cancer	0.00173	0.00173	CcSEcCtD
Gadobutrol—Rash—Paclitaxel—kidney cancer	0.00172	0.00172	CcSEcCtD
Gadobutrol—Dermatitis—Paclitaxel—kidney cancer	0.00172	0.00172	CcSEcCtD
Gadobutrol—Headache—Paclitaxel—kidney cancer	0.00171	0.00171	CcSEcCtD
Gadobutrol—Hypersensitivity—Capecitabine—kidney cancer	0.00165	0.00165	CcSEcCtD
Gadobutrol—Nausea—Paclitaxel—kidney cancer	0.00162	0.00162	CcSEcCtD
Gadobutrol—Vertigo—Doxorubicin—kidney cancer	0.00159	0.00159	CcSEcCtD
Gadobutrol—Palpitations—Doxorubicin—kidney cancer	0.00156	0.00156	CcSEcCtD
Gadobutrol—Convulsion—Doxorubicin—kidney cancer	0.00153	0.00153	CcSEcCtD
Gadobutrol—Diarrhoea—Capecitabine—kidney cancer	0.00153	0.00153	CcSEcCtD
Gadobutrol—Dizziness—Capecitabine—kidney cancer	0.00148	0.00148	CcSEcCtD
Gadobutrol—Dry mouth—Doxorubicin—kidney cancer	0.00147	0.00147	CcSEcCtD
Gadobutrol—Anaphylactic shock—Doxorubicin—kidney cancer	0.00144	0.00144	CcSEcCtD
Gadobutrol—Infection—Doxorubicin—kidney cancer	0.00143	0.00143	CcSEcCtD
Gadobutrol—Vomiting—Capecitabine—kidney cancer	0.00142	0.00142	CcSEcCtD
Gadobutrol—Rash—Capecitabine—kidney cancer	0.00141	0.00141	CcSEcCtD
Gadobutrol—Dermatitis—Capecitabine—kidney cancer	0.00141	0.00141	CcSEcCtD
Gadobutrol—Headache—Capecitabine—kidney cancer	0.0014	0.0014	CcSEcCtD
Gadobutrol—Hyperhidrosis—Doxorubicin—kidney cancer	0.0014	0.0014	CcSEcCtD
Gadobutrol—Nausea—Capecitabine—kidney cancer	0.00133	0.00133	CcSEcCtD
Gadobutrol—Insomnia—Doxorubicin—kidney cancer	0.00131	0.00131	CcSEcCtD
Gadobutrol—Paraesthesia—Doxorubicin—kidney cancer	0.0013	0.0013	CcSEcCtD
Gadobutrol—Dyspnoea—Doxorubicin—kidney cancer	0.00129	0.00129	CcSEcCtD
Gadobutrol—Pain—Doxorubicin—kidney cancer	0.00123	0.00123	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00118	0.00118	CcSEcCtD
Gadobutrol—Abdominal pain—Doxorubicin—kidney cancer	0.00114	0.00114	CcSEcCtD
Gadobutrol—Body temperature increased—Doxorubicin—kidney cancer	0.00114	0.00114	CcSEcCtD
Gadobutrol—Hypersensitivity—Doxorubicin—kidney cancer	0.00106	0.00106	CcSEcCtD
Gadobutrol—Diarrhoea—Doxorubicin—kidney cancer	0.000987	0.000987	CcSEcCtD
Gadobutrol—Dizziness—Doxorubicin—kidney cancer	0.000954	0.000954	CcSEcCtD
Gadobutrol—Vomiting—Doxorubicin—kidney cancer	0.000918	0.000918	CcSEcCtD
Gadobutrol—Rash—Doxorubicin—kidney cancer	0.00091	0.00091	CcSEcCtD
Gadobutrol—Dermatitis—Doxorubicin—kidney cancer	0.000909	0.000909	CcSEcCtD
Gadobutrol—Headache—Doxorubicin—kidney cancer	0.000904	0.000904	CcSEcCtD
Gadobutrol—Nausea—Doxorubicin—kidney cancer	0.000857	0.000857	CcSEcCtD
